Effect of multifactorial intervention on quality of life and cost-effectiveness in newly diagnosed type 2 diabetic patients

Chinese Journal of Evidence-Based Medicine

Volumn 5, Issue 5, 2005, Pages 386-390

  Liu, Zhi Wen ^a   Zhou, Zhi Guang ^a   Chen, Xiao Yan ^a   Tang, Wei Li ^a   Peng, Jian ^a   Feng, Qiong ^a   Ning, Jie ^a   He, Xia ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Intensive intervention; Pharmacoeconomics; Quality of life; SF 36 health questionary; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C;

BLOOD PRESSURE; COST EFFECTIVENESS ANALYSIS; EMOTIONAL STABILITY; FEMALE; GENERAL CONDITION; GLUCOSE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; POLICY; QUALITY OF LIFE; REGRESSION ANALYSIS; REVIEW; SCORING SYSTEM; SHORT FORM 36;

EID: 20144369001     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S, Runzo C, Prina Cerai S, Pagano G, Cavallo-Perin P. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: The Casale Monferrato Study [J]. Diabetes Care, 2004; 27(11): 2689-2694.
2. Manuel DG, Schultz SE. Health-related quality of life and health-adjusted life expectancy of people with diabetes in Ontario, Canada, 1996-1997 [J]. Diabetes Care, 2004; 27(2): 407-414.
3. Redekop WK, Koopmanschap MA, Stolk RP. Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes [J]. Diabetes Care, 2002; 25(3): 458-463.
4. UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38) [J]. BMJ, 1998; 317(7160); 703-713.
5. Abraira C, Duckworth W, McCarren M, Emanuele N, Arca D, Reda D, Henderson W. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial [J]. Diabetes Complications, 2003; 17(6): 314-322.
6. Gaede PH, Jepsen PV, Larsen JN, Jensen GV, Parving HH, Pedersen OB. The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes [J]. Ugeskr Laeger, 2003; 165(26): 2658-2661.
7. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes [J]. N Engl J Med, 2003; 348(5): 383-393.
8. Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, Stratton I, Adler A, Holman R, Turner R. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) [J]. BMJ, 2000; 320(7 246): 1373-1378.
9. Diabetes Control and Complications Trial (DCCT). Influence of intensive diabetes treatment on quality-of-life outcomes in the diabetes control and complications trial [J]. Diabetes Care, 1996; 19(3): 195-203.
10. Maddigan SL, Majumdar SR, Guirguis LM, Lewanczuk RZ, Lee TK, Toth EL, Johnson JA. Improvements in patient-reported outcomes associated with an intervention to enhance quality of care for rural patients with type 2 diabetes: Results of a controlled trial [J]. Diabetes Care, 2004; 27(6): 1306-1312.
11. McMurray SD, Johnson G, Davis S, McDougall KQ. Diabetes education and care management significantly improve patient outcomes in the dialysis unit [J]. Am J Kidney Dis, 2002; 40(3): 566-575.
12. Nicollerat JA. Implications of the United Kingdom Prospective Diabetes Study (UKPDS) results on patient management [J]. Diabetes Educ, 2000; 26(Suppl): 8-10.
13. UKPDS. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37) [J]. Diabetes Care, 1999; 22 (7): 1125-1136.
14. Hanefeld M, Fischer S, Schmechel H, Rothe G, Schulze J, Dude H, Schwanebeck U, Julius U. Diabetes Intervention Study. Multi-intervention trial in newly diagnosed NIDDM [J]. Diabetes Care, 1991; 14(4): 308-317.